Pulmonary tuberculosis, oxazolidinones, phase 2b, randomised clinical trial
Tuberculosis, btz-043, benzothiazinones, randomised trial, early bactericidal activity
Sputum microbiome surrogate for respiratory microbiome, anti-tuberculosis antibiotics, tuberculosis treatment, impact on microbiome, anti-tuberculosis drug development strategies.